The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Resource utilization (RU) and toxicities after carboplatin/etoposide/melphalan (CEM) and busulfan/melphalan (BuMel) for autologous stem cell rescue (ASCR) in high-risk neuroblastoma (HRNB).
 
Ami Vijay Desai
No Relationships to Disclose
 
Yimei Li
Stock and Other Ownership Interests - Juno Therapeutics
 
Mallorie Heneghan
No Relationships to Disclose
 
Yuan-Shung Huang
No Relationships to Disclose
 
Brian Fisher
Research Funding - Merck (Inst); Pfizer (Inst)
 
Adjoa Mante
No Relationships to Disclose
 
Stephan A. Grupp
Consulting or Advisory Role - Novartis
 
Nancy J. Bunin
No Relationships to Disclose
 
Richard Aplenc
No Relationships to Disclose
 
Rochelle Bagatell
No Relationships to Disclose
 
Alix Eden Seif
No Relationships to Disclose